404 related articles for article (PubMed ID: 16625859)
21. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
Hasskarl J; Kaufmann M; Schmid HA
Future Oncol; 2011 Jul; 7(7):895-913. PubMed ID: 21732759
[TBL] [Abstract][Full Text] [Related]
22. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
23. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
24. Null mutant mouse models of somatostatin and cortistatin, and their receptors.
Zeyda T; Hochgeschwender U
Mol Cell Endocrinol; 2008 May; 286(1-2):18-25. PubMed ID: 18206294
[TBL] [Abstract][Full Text] [Related]
25. Prolonged somatostatin therapy may cause down-regulation of SSTR-like GPCRs on Schistosoma mansoni.
Chatterjee S; Op De Beeck J; Rao AV; Desai DV; Vrolix G; Rylant F; Panis T; Bernat A; Van Bergen J; Peeters D; Van Marck E
J Vector Borne Dis; 2007 Sep; 44(3):164-80. PubMed ID: 17896619
[TBL] [Abstract][Full Text] [Related]
26. Perspectives of new potential therapeutic applications of somatostatin analogs.
Pawlikowski M; Melen-Mucha G
Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors.
Janson ET
J Endocrinol Invest; 2005; 28(11 Suppl International):137-40. PubMed ID: 16625863
[TBL] [Abstract][Full Text] [Related]
28. Function and expression of somatostatin receptors of the endocrine pancreas.
Strowski MZ; Blake AD
Mol Cell Endocrinol; 2008 May; 286(1-2):169-79. PubMed ID: 18375050
[TBL] [Abstract][Full Text] [Related]
29. Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues.
Dalm VA; Van Hagen PM; de Krijger RR; Kros JM; Van Koetsveld PM; Van Der Lely AJ; Lamberts SW; Hofland LJ
Clin Endocrinol (Oxf); 2004 May; 60(5):625-9. PubMed ID: 15104567
[TBL] [Abstract][Full Text] [Related]
30. Cortistatin: a natural somatostatin analog.
de Lecea L
J Endocrinol Invest; 2005; 28(11 Suppl International):10-4. PubMed ID: 16625839
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin and the gastrointestinal tract.
Corleto VD
Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):63-8. PubMed ID: 19907319
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
Watt HL; Kharmate GD; Kumar U
Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
[TBL] [Abstract][Full Text] [Related]
33. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptor distribution and function in immune system.
Ferone D; van Hagen PM; Semino C; Dalm VA; Barreca A; Colao A; Lamberts SW; Minuto F; Hofland LJ
Dig Liver Dis; 2004 Feb; 36 Suppl 1():S68-77. PubMed ID: 15077914
[TBL] [Abstract][Full Text] [Related]
35. Regulation of somatostatins and their receptors in fish.
Nelson LE; Sheridan MA
Gen Comp Endocrinol; 2005 May; 142(1-2):117-33. PubMed ID: 15862556
[TBL] [Abstract][Full Text] [Related]
36. Organization of the human immune system.
Waldmann TA
Dermatol Clin; 1990 Oct; 8(4):593-607. PubMed ID: 2249353
[TBL] [Abstract][Full Text] [Related]
37. Potential indications for somatostatin analogs in Cushing's syndrome.
Arnaldi G; Polenta B; Cardinaletti M; Boscaro M
J Endocrinol Invest; 2005; 28(11 Suppl International):106-10. PubMed ID: 16625858
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.
Florio T
Mol Cell Endocrinol; 2008 May; 286(1-2):40-8. PubMed ID: 17913342
[TBL] [Abstract][Full Text] [Related]
39. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptides and their receptors in the immune system.
van Hagen PM; Hofland LJ; ten Bokum AM; Lichtenauer-Kaligis EG; Kwekkeboom DJ; Ferone D; Lamberts SW
Ann Med; 1999 Oct; 31 Suppl 2():15-22. PubMed ID: 10574150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
